Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion type Assertion NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_head.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion description "[As part of our HPV-PathogenISS study, a series of 150 squamous cell carcinomas (SCC) and 152 CIN lesions were examined using immunohistochemical (IHC) staining for topoisomerase IIalpha (topo IIalpha), and tested for HPV using PCR with three primer sets (MY09/11, GP5/GP6, SPF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_provenance.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion evidence source_evidence_literature NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_provenance.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion SIO_000772 16990717 NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_provenance.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion wasDerivedFrom befree-20140225 NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_provenance.
- NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_assertion wasGeneratedBy ECO_0000203 NP651516.RAJXZHB9Kx-II-OD6SsaB4HK1iaG3o_cpS_IrXgG94cm4130_provenance.